Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials

Based on the development of ceftazidime-avibactam the authors propose a strategy for developing a new framework based on adaptive, post-marketing randomised clinical trials.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news